Artificial Saliva

Global Artificial Saliva Market to Reach US$3.5 Billion by 2030

The global market for Artificial Saliva estimated at US$1.6 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 13.5% over the analysis period 2024-2030. Oral Sprays, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Oral Liquids segment is estimated at 13.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$452.8 Million While China is Forecast to Grow at 12.7% CAGR

The Artificial Saliva market in the U.S. is estimated at US$452.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$532.4 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 11.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Global Artificial Saliva Market - Key Trends and Drivers Summarized

Why Is Artificial Saliva Gaining Importance in Oral Healthcare?

Artificial saliva has become an essential product in oral healthcare, particularly for individuals suffering from xerostomia, commonly known as dry mouth. This condition, often caused by certain medications, autoimmune diseases like Sjögren’s syndrome, radiation therapy, or aging, results in a decrease in saliva production, leading to discomfort, difficulty in speaking, swallowing, and an increased risk of dental cavities and infections. Artificial saliva products are designed to mimic the properties of natural saliva, providing lubrication, moisture, and relief from the symptoms of dry mouth. These products come in various forms, including sprays, gels, lozenges, and rinses, making them accessible and easy to use for those who need regular relief. As awareness of dry mouth and its associated risks grows, artificial saliva is increasingly recognized as a crucial component in maintaining oral health and improving the quality of life for affected individuals.

How Are Technological Advances Improving the Efficacy of Artificial Saliva?

The efficacy of artificial saliva products has significantly improved due to recent technological advancements in formulation and delivery methods. Modern artificial saliva products are formulated to closely replicate the composition and functionality of natural saliva, including the presence of essential enzymes, electrolytes, and moisturizing agents that help protect oral tissues and prevent dental decay. Innovations in the delivery systems of these products have also enhanced their effectiveness. For example, sustained-release formulations that provide long-lasting moisture have been developed, reducing the need for frequent application. Additionally, the introduction of more palatable flavors and pH-balanced formulations has improved user compliance, as patients are more likely to use products that are comfortable and pleasant. These advancements are making artificial saliva a more effective and reliable solution for managing dry mouth symptoms, thereby broadening its appeal and usage among patients.

What Market Trends Are Influencing the Adoption of Artificial Saliva Products?

Several market trends are influencing the growing adoption of artificial saliva products. The aging global population is a significant factor, as older adults are more likely to experience dry mouth due to age-related changes and the increased use of medications that reduce saliva production. Additionally, the rising prevalence of chronic conditions such as diabetes, cancer, and autoimmune disorders, which are often associated with dry mouth, is driving demand for effective treatment options like artificial saliva. The shift towards patient-centered care, where the focus is on improving the overall quality of life for patients, has also played a role in the increased use of artificial saliva, as healthcare providers seek to offer comprehensive solutions that address not only the primary condition but also the secondary symptoms like dry mouth. Furthermore, growing awareness of the importance of oral health and its connection to overall well-being is encouraging more individuals to seek treatment for dry mouth, thereby boosting the market for artificial saliva products.

What Factors Are Driving the Growth of the Artificial Saliva Market?

The growth in the artificial saliva market is driven by several factors that are shaping its development and expansion. A primary driver is the increasing prevalence of conditions associated with dry mouth, such as Sjögren’s syndrome, diabetes, and the side effects of cancer treatments like radiation therapy. Technological advancements in product formulations, including the development of longer-lasting and more effective artificial saliva, are enhancing the appeal and efficacy of these products, leading to higher adoption rates. The expanding elderly population, particularly in developed countries, is also contributing to market growth as this demographic is more prone to dry mouth and seeks solutions to manage it effectively. Additionally, the increasing availability of artificial saliva products through both prescription and over-the-counter channels is making these solutions more accessible to a broader audience. The rise in consumer awareness about the importance of oral health and the impact of dry mouth on quality of life is further propelling market demand, as more individuals seek out products that can provide relief and improve their daily comfort.

SCOPE OF STUDY:

The report analyzes the Artificial Saliva market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Oral Sprays, Oral Liquids, Gels, Oral Solutions, Powders)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 18 Featured) -

• Bausch Health Companies Inc.
• Biocosmetics Laboratories
• CCMed Ltd
• Cipla Ltd.
• Forward Science
• Fresenius Kabi AG
• GlaxoSmithKline PLC
• ICPA Health Pvt. Ltd.
• Laboratorios Kin S.A.
• Midatech Pharma PLC
• Mission Pharmacal Company
• Perrigo Company PLC

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.